project id: TCGA-ESCA; case submitter id: TCGA-V5-A7RB; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.64; rna integrity number: 9.3; age at index: 59; days to birth: -21654; days to death: 161; ethnicity: hispanic or latino; gender: male; race: not reported; vital status: Dead; age at diagnosis: 21654; ajcc clinical m: MX; ajcc clinical n: N1; ajcc clinical stage: Stage IIB; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic t: T0; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C15.5; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower third of esophagus; synchronous malignancy: No; tissue or organ of origin: Lower third of esophagus; tumor grade: Not Reported; treatment or therapy: no; alcohol history: Yes; cigarettes per day: 2.191780821917808; pack years smoked: 40.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 10.0; portion submitter id: TCGA-V5-A7RB-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 1.0; percent normal cells: 50.0; percent stromal cells: 10.0; percent tumor cells: 40.0; percent tumor nuclei: 60.0;